Corps, Navy, Air Force, Space Force, Coast Guard, 11 combatant commands, other Federal agencies, and partner and allied nations. (8) DLA has supported the COVID–19 response of the Department of Defense by increasing the production and acquisition of critical items through existing large-scale contracts across multiple supply chains. (9) As a logistics integrator and acquisition and service provider, DLA has the unique capability to manage the supply chain that few other organizations, public or private, can match to assist States, local governments, hospitals, and health care providers around the country with supplies so they are not needlessly competing against one another. (10) Additionally, the COVID–19 Joint Acquisition Task Force ( JATF ), established by the Under Secretary of Defense for Acquisition and Sustainment, plays a critical role in the national response to the COVID–19 pandemic. (11) The JATF’s understanding of reliance on foreign suppliers, often many tiers down in the supply chain, and the impact of that reliance on producing at scale has allowed the Secretary of Health and Human Services to better plan for replenishment of the Strategic National Stockpile. (12) DLA should provide direct support for States during the COVID–19 pandemic and future emergencies. (13) DLA can identify private sector capacity and assess additional needs for vaccines and supplies during the COVID–19 pandemic and during future emergencies. (14) The Department of Health and Human Services estimated that healthcare providers may need 3,500,000,000 face masks to meet potential long-term need. (15) Testing capacity and testing materials have not met existing needs, as well as therapeutics. 3. Use of Defense Production Act authority for equipment necessary for limiting spread of COVID-19 (a) In general Immediately upon the enactment of this Act, the President shall— (1) determine under section 101(b) of the Defense Production Act of 1950 ( 50 U.S.C. 4511(b) ) that— (A) medical equipment and supplies, testing materials,